Cargando…

Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems

Micro- and nano-carrier formulations have been developed as drug delivery systems for active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, pharmacokinetic, and pharmacodynamic properties. Encapsulating the APIs in such systems can help improve their stability by protectin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakravarty, Paroma, Famili, Amin, Nagapudi, Karthik, Al-Sayah, Mohammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956038/
https://www.ncbi.nlm.nih.gov/pubmed/31775292
http://dx.doi.org/10.3390/pharmaceutics11120629
_version_ 1783487068077293568
author Chakravarty, Paroma
Famili, Amin
Nagapudi, Karthik
Al-Sayah, Mohammad A.
author_facet Chakravarty, Paroma
Famili, Amin
Nagapudi, Karthik
Al-Sayah, Mohammad A.
author_sort Chakravarty, Paroma
collection PubMed
description Micro- and nano-carrier formulations have been developed as drug delivery systems for active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, pharmacokinetic, and pharmacodynamic properties. Encapsulating the APIs in such systems can help improve their stability by protecting them from harsh conditions such as light, oxygen, temperature, pH, enzymes, and others. Consequently, the API’s dissolution rate and bioavailability are tremendously improved. Conventional techniques used in the production of these drug carrier formulations have several drawbacks, including thermal and chemical stability of the APIs, excessive use of organic solvents, high residual solvent levels, difficult particle size control and distributions, drug loading-related challenges, and time and energy consumption. This review illustrates how supercritical fluid (SCF) technologies can be superior in controlling the morphology of API particles and in the production of drug carriers due to SCF’s non-toxic, inert, economical, and environmentally friendly properties. The SCF’s advantages, benefits, and various preparation methods are discussed. Drug carrier formulations discussed in this review include microparticles, nanoparticles, polymeric membranes, aerogels, microporous foams, solid lipid nanoparticles, and liposomes.
format Online
Article
Text
id pubmed-6956038
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69560382020-01-23 Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems Chakravarty, Paroma Famili, Amin Nagapudi, Karthik Al-Sayah, Mohammad A. Pharmaceutics Review Micro- and nano-carrier formulations have been developed as drug delivery systems for active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, pharmacokinetic, and pharmacodynamic properties. Encapsulating the APIs in such systems can help improve their stability by protecting them from harsh conditions such as light, oxygen, temperature, pH, enzymes, and others. Consequently, the API’s dissolution rate and bioavailability are tremendously improved. Conventional techniques used in the production of these drug carrier formulations have several drawbacks, including thermal and chemical stability of the APIs, excessive use of organic solvents, high residual solvent levels, difficult particle size control and distributions, drug loading-related challenges, and time and energy consumption. This review illustrates how supercritical fluid (SCF) technologies can be superior in controlling the morphology of API particles and in the production of drug carriers due to SCF’s non-toxic, inert, economical, and environmentally friendly properties. The SCF’s advantages, benefits, and various preparation methods are discussed. Drug carrier formulations discussed in this review include microparticles, nanoparticles, polymeric membranes, aerogels, microporous foams, solid lipid nanoparticles, and liposomes. MDPI 2019-11-25 /pmc/articles/PMC6956038/ /pubmed/31775292 http://dx.doi.org/10.3390/pharmaceutics11120629 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chakravarty, Paroma
Famili, Amin
Nagapudi, Karthik
Al-Sayah, Mohammad A.
Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
title Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
title_full Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
title_fullStr Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
title_full_unstemmed Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
title_short Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
title_sort using supercritical fluid technology as a green alternative during the preparation of drug delivery systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956038/
https://www.ncbi.nlm.nih.gov/pubmed/31775292
http://dx.doi.org/10.3390/pharmaceutics11120629
work_keys_str_mv AT chakravartyparoma usingsupercriticalfluidtechnologyasagreenalternativeduringthepreparationofdrugdeliverysystems
AT familiamin usingsupercriticalfluidtechnologyasagreenalternativeduringthepreparationofdrugdeliverysystems
AT nagapudikarthik usingsupercriticalfluidtechnologyasagreenalternativeduringthepreparationofdrugdeliverysystems
AT alsayahmohammada usingsupercriticalfluidtechnologyasagreenalternativeduringthepreparationofdrugdeliverysystems